<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for http://feeds.benzinga.com/benzinga</title><link>http://feeds.benzinga.com/benzinga</link><description>Individual feed output.</description><lastBuildDate>Thu, 11 Sep 2025 17:26:44 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Bitcoin At A Crossroad: Why You Need To Watch $108,000 And $116,000</title><link>https://www.benzinga.com/crypto/cryptocurrency/25/09/47629537/bitcoin-at-a-crossroad-why-you-need-to-watch-108000-and-116000</link><image_url>https://cdn.benzinga.com/files/images/story/2025/09/11/A-Futuristic-Digital-themed-Illustration.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>On-chain data shows that Bitcoin (CRYPTO: BTC ) is holding a crucial support level at $114,000, with markets now at a crossroads that could define its...</description><pubDate>Thu, 11 Sep 2025 19:42:41 GMT</pubDate></item><item><title>Anglo Teck: A New Copper Empire Is Quietly Taking Shape</title><link>https://www.benzinga.com/markets/commodities/25/09/47629466/anglo-teck-a-new-copper-empire-is-quietly-taking-shape</link><image_url>https://cdn.benzinga.com/files/images/story/2025/09/11/Shanghai--China---March-19--2019-Bales-O.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Anglo American's tie-up with Teck could reshape the global commodities map. The merged company will have a strong focus on copper and generate signifi...</description><pubDate>Thu, 11 Sep 2025 19:39:29 GMT</pubDate></item><item><title>Oracle's 40% Moonshot Put Defiance's ORCX ETF On The Map</title><link>https://www.benzinga.com/etfs/specialty-etfs/25/09/47629173/oracles-40-moonshot-put-defiances-orcx-etf-on-the-map</link><image_url>https://cdn.benzinga.com/files/images/story/2025/09/11/Deerfield---Circa-June-2019-Oracle-Corpo.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Defiance CEO Sylvia Jablonski on ORCX's amplified Oracle rally, the risks of leverage, and why single-stock ETFs suit short-term AI trades. read more</description><pubDate>Thu, 11 Sep 2025 19:25:29 GMT</pubDate></item><item><title>Buffett, Ackman, Ives Are Now ETF Brandsâ€”And It's Changing The Game</title><link>https://www.benzinga.com/etfs/specialty-etfs/25/09/47629043/buffett-ackman-ives-are-now-etf-brands-and-its-changing-the-game</link><image_url>https://cdn.benzinga.com/files/images/story/2025/09/11/Clean-Energy-ETFs-In-Focus-As-Trump-Halt.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>From Buffett's OMAH to Ackman's ACKY, the rise of personality ETFs is giving investors access to legendary strategies with unique twists. read more</description><pubDate>Thu, 11 Sep 2025 19:18:33 GMT</pubDate></item><item><title>Analysts Raise Price Targets Following Strong Data From Revolution Medicines' Pancreatic Cancer Drug</title><link>https://www.benzinga.com/analyst-stock-ratings/price-target/25/09/47628962/analysts-raise-price-targets-following-strong-data-from-revolution-medicines-p</link><image_url>https://cdn.benzinga.com/files/images/story/2025/09/11/Revolution-Medicines.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Revolution Medicines reports positive results from daraxonrasib trials in metastatic pancreatic cancer, with strong response rates and consistent safe...</description><pubDate>Thu, 11 Sep 2025 19:14:44 GMT</pubDate></item></channel></rss>